TFPI and invasive breast carcinoma: Our study provides evidence that BrCa patients, regardless of coexisting diseases, not only display higher levels of TF protein but also lower levels of (TF) pathway inhibitor, resulting in a shift of the TF/TFPI ratio towards excess TF relative to healthy post-menopausal cases.